About this blog

CRIT is no longer adding posts or updating the CRITical Thinking blog.

CRITical Thinking is a blog written by staff, directors, and friends of the Collaboration for Research Integrity and Transparency (CRIT), a joint program of Yale Law School, Yale School of Public Health, and Yale School of Medicine. CRIT's mission is to promote health by improving the integrity and transparency of biomedical and clinical research.

This blog is published by and reflects the personal views of the individual authors, in their individual capacities. It does not purport to represent Yale University's institutional views, if any. No representation is made about the accuracy of the information, which solely constitutes the authors’ personal views on issues discussed. The information contained in this blog is provided only as general information and personal opinions, and blog topics may be updated after being initially posted.

 

CRITical Thinking Blog

Are Payers Willing to Engage in Evidence-based Coverage Decisions?

August 29, 2017
By Dan Ollendorf

In June 2017, Yale CRIT hosted an international conference titled “Ensuring Safety, Efficacy, and Access to Medical Products in the Age of Global Deregulation.” The following blogpost is the fourth installment of a blog series with commentaries from the conference participants.

Read more

What is the State of the Evidence Base for Medical Products We Use Currently?

August 24, 2017
By Tom Jefferson

In June 2017, Yale CRIT hosted an international conference titled “Ensuring Safety, Efficacy, and Access to Medical Products in the Age of Global Deregulation.” The following blogpost is the third installment of a blog series with commentaries from the conference participants.

Read more

Why High Quality Evidence Matters: Lessons from HIV Activism and Drug Development

August 21, 2017
By Simon Collins

In June 2017, Yale CRIT hosted an international conference titled “Ensuring Safety, Efficacy, and Access to Medical Products in the Age of Global Deregulation.” The following blogpost is the second installment of a blog series with commentaries from the conference participants.

Read more

Deregulatory Pressures on the FDA

August 16, 2017
By Alison Bateman-House, Arthur Caplan

In June 2017, Yale CRIT hosted an international conference titled “Ensuring Safety, Efficacy, and Access to Medical Products in the Age of Global Deregulation.” The following blogpost is the first installment of a blog series with commentaries from the conference participants.

Read more

Pages